Travere Therapeutics
TVTX
#4650
Rank
S$2.05 B
Marketcap
$23.15
Share price
5.57%
Change (1 day)
212.10%
Change (1 year)

EPS for Travere Therapeutics (TVTX)

EPS in 2023 (TTM): -$6.16

According to Travere Therapeutics's latest financial reports the company's current EPS (TTM) is -$5.94. In 2022 the company made an earnings per share (EPS) of -$5.74 a decrease over its 2021 EPS that were of -$3.98.

EPS history for Travere Therapeutics from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$6.167.33%
2022-$5.7444.22%
2021-$3.98-10.09%
2020-$4.43-2.6%
2019-$4.5436.22%
2018-$3.3464.94%
2017-$2.0220.31%
2016-$1.68-135.46%
2015$4.74-175.68%
2014-$6.2698.75%
2013-$3.151746.15%
2012-$0.171.34%
2011-$0.17

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.31-77.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.35-94.03%๐Ÿ‡บ๐Ÿ‡ธ USA